CALYPTE BIOMEDICAL CORP Operating Cash Flow
CALYPTE BIOMEDICAL CORP reported Operating Cash Flow of -$682.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2014-06-24.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2014-06-24
- CALYPTE BIOMEDICAL CORP net cash provided by (used in) operating activities for the quarter ending 2012-12-31 was -$138.00K.
- CALYPTE BIOMEDICAL CORP net cash provided by (used in) operating activities for the quarter ending 2012-09-30 was -$136.00K.
- CALYPTE BIOMEDICAL CORP net cash provided by (used in) operating activities for the quarter ending 2012-06-30 was -$141.00K.
- CALYPTE BIOMEDICAL CORP net cash provided by (used in) operating activities for the quarter ending 2012-03-31 was -$267.00K, a 429.63% decline year-over-year.
- CALYPTE BIOMEDICAL CORP net cash provided by (used in) operating activities for fiscal 2012 was -$682.00K.
- CALYPTE BIOMEDICAL CORP net cash provided by (used in) operating activities for fiscal 2011 was -$443.00K.
- CALYPTE BIOMEDICAL CORP net cash provided by (used in) operating activities for fiscal 2010 was -$682.00K.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2012-12-31 | -$138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-24 | -$274.00K derived: sum of 2 quarters · filed 2014-06-24 | -$415.00K derived: sum of 3 quarters · filed 2014-06-24 | -$682.00K 10-K · filed 2014-06-24 |
| 2012-09-30 | -$136.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-12-31 | -$277.00K derived: sum of 2 quarters · filed 2012-12-31 | -$544.00K 10-Q · filed 2012-12-31 | -$744.00K derived: sum of 4 quarters · filed 2014-06-24 |
| 2012-06-30 | -$141.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$408.00K 10-Q · filed 2012-08-14 | -$608.00K derived: sum of 3 quarters · filed 2014-06-24 | -$770.00K derived: sum of 4 quarters · filed 2014-06-24 |
| 2012-03-31 | -$267.00K 10-Q · filed 2012-05-15 | -$467.00K derived: sum of 2 quarters · filed 2014-06-24 | -$629.00K derived: sum of 3 quarters · filed 2014-06-24 | -$791.00K derived: sum of 4 quarters · filed 2014-06-24 |
| 2011-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-24 | -$362.00K derived: sum of 2 quarters · filed 2014-06-24 | -$524.00K derived: sum of 3 quarters · filed 2014-06-24 | -$443.00K 10-K · filed 2014-06-24 |
| 2011-09-30 | -$162.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-12-31 | -$324.00K derived: sum of 2 quarters · filed 2012-12-31 | -$243.00K 10-Q · filed 2012-12-31 | -$296.00K derived: sum of 4 quarters · filed 2012-12-31 |
| 2011-06-30 | -$162.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$81.00K 10-Q · filed 2012-08-14 | -$134.00K derived: sum of 3 quarters · filed 2012-08-14 | -$312.00K derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $81.00K 10-Q · filed 2012-05-15 | $28.00K derived: sum of 2 quarters · filed 2012-05-15 | -$150.00K derived: sum of 3 quarters · filed 2012-05-15 | |
| 2010-12-31 | -$53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-22 | -$231.00K derived: sum of 2 quarters · filed 2012-03-22 | -$682.00K 10-K · filed 2012-03-22 | |
| 2010-09-30 | -$178.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-01-27 | -$629.00K 10-Q · filed 2012-01-27 | ||
| 2010-06-30 | -$451.00K 10-Q/A · filed 2011-11-30 |